Jiangsu Hengrui Medicine
600276.SS
#465
Rank
S$58.27 B
Marketcap
$9.14
Share price
-1.00%
Change (1 day)
1.28%
Change (1 year)
Jiangsu Hengrui Medicine Company Limited is a Chinese pharmaceutical company engaged in the R&D, manufacturing and sales of healthcare products, including antineoplastic drugs, angiomyocardiac drugs, drugs for surgery, contrast agents and antibiotics

Jiangsu Hengrui Medicine (600276.SS) - Total assets

Total assets on the balance sheet as of September 2024 : S$9.10 Billion

According to Jiangsu Hengrui Medicine 's latest financial reports the company's total assets are S$9.10 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Jiangsu Hengrui Medicine - Total assets on balance sheet (from 2001 to 2024)

Total assets by year

Year Total assets Change
2022-12-31S$8.23 B-1.18%
2021-12-31S$8.33 B18.26%
2020-12-31S$7.04 B32.46%
2019-12-31S$5.31 B18.92%
2018-12-31S$4.47 B20.58%
2017-12-31S$3.70 B24.17%
2016-12-31S$2.98 B19.04%
2015-12-31S$2.50 B29.4%
2014-12-31S$1.93 B28.28%
2013-12-31S$1.51 B30.79%
2012-12-31S$1.15 B16.42%
2011-12-31S$0.99 B30.82%
2010-12-31S$0.75 B23.12%
2009-12-31S$0.61 B30.26%
2008-12-31S$0.47 B16.55%
2007-12-31S$0.40 B40.74%
2006-12-31S$0.28 B8.76%
2005-12-31S$0.26 B7.05%
2004-12-31S$0.24 B-16.9%
2003-12-31S$0.29 B18.07%
2002-12-31S$0.25 B0.89%
2001-12-31S$0.25 B